AbbVie Inc. (ABBV)
NYSE: ABBV · IEX Real-Time Price · USD
165.88
-0.54 (-0.32%)
May 20, 2024, 11:06 AM EDT - Market open
AbbVie Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for AbbVie stock have an average target of 180.55, with a low estimate of 150 and a high estimate of 200. The average target predicts an increase of 8.84% from the current stock price of 165.88.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for AbbVie stock from 12 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 6 | 7 | 8 | 7 | 6 | 7 |
| Hold | 8 | 7 | 7 | 3 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 17 | 17 | 18 | 13 | 11 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $200 | Buy | Initiates | $200 | +20.57% | May 17, 2024 |
| Barclays | Barclays | Buy Maintains $195 → $187 | Buy | Maintains | $195 → $187 | +12.73% | Apr 29, 2024 |
| BMO Capital | BMO Capital | Buy Maintains $195 → $180 | Buy | Maintains | $195 → $180 | +8.51% | Apr 29, 2024 |
| Barclays | Barclays | Buy Maintains $185 → $195 | Buy | Maintains | $185 → $195 | +17.55% | Mar 27, 2024 |
| Guggenheim | Guggenheim | Strong Buy Maintains $188 → $190 | Strong Buy | Maintains | $188 → $190 | +14.54% | Mar 22, 2024 |
Financial Forecast
Revenue This Year
55.65B
from 54.32B
Increased by 2.46%
Revenue Next Year
59.08B
from 55.65B
Increased by 6.15%
EPS This Year
11.41
from 2.72
Increased by 319.39%
EPS Next Year
12.45
from 11.41
Increased by 9.15%
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 58.2B | 63.8B | 69.0B | 74.0B | 78.4B |
| Avg | 55.7B | 59.1B | 63.3B | 67.5B | 71.7B |
| Low | 52.8B | 54.6B | 57.1B | 62.3B | 65.6B |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 7.1% | 14.7% | 16.8% | 16.8% | 16.2% |
| Avg | 2.5% | 6.2% | 7.2% | 6.6% | 6.3% |
| Low | -2.8% | -1.9% | -3.4% | -1.5% | -2.8% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 12.03 | 13.70 | 15.16 | 16.29 | 18.09 |
| Avg | 11.41 | 12.45 | 13.75 | 14.88 | 16.23 |
| Low | 10.63 | 11.27 | 12.40 | 13.29 | 14.27 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 342.4% | 20.1% | 21.8% | 18.4% | 21.6% |
| Avg | 319.4% | 9.1% | 10.4% | 8.2% | 9.1% |
| Low | 290.9% | -1.2% | -0.4% | -3.4% | -4.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.